The National Nuclear Security Administration did not audit more than $10 million paid to one of four companies manufacturing Molybdenum-99 for use in medical procedures, the Department of Energy Inspector General said last week.
In an effort to spur domestic…
SUBSCRIBER ACCESS
Thank you for visiting
Nuclear Security & Deterrence Monitor!
You must be logged in as a subscriber to view this page.






